US 11,452,722 B2Granted

Stable pharmaceutical compositions comprising lenalidomide

AssigneeNatco Pharma Limited

InventorsVattikuti Satyanarayana, Bhavanasi Krishna Murthy, Vemuri Venkata Suresh Babu, Bhat Pavan, Nannapaneni Venkaiah Chowdary

Life of this patent

Estimating the term…

Abstract

The present invention relates to pharmaceutical compositions comprising Lenalidomide. More particularly, the present invention relates to a stable composition comprising anhydrous Lenalidomide Form I and one or more pharmaceutically acceptable excipients and process for preparing such compositions.

Claims3

Dependent claims

A capsule containing a stable composition consisting of anhydrous Lenalidomide Form I and lactose anhydrous.

Dependencies are inferred from the claim text.

Facts

Application: 16/962,131Filed 7 Jan 2019
Priority: IN 20184100128111 Jan 2018
Published: US 2021/0196698 A11 Jul 2021
Granted: 27 Sep 2022
Term ends: Not estimatedThe source records don’t support an estimate.

Classification10 codes

A61K 31/454
Containing further heterocyclic ring systems: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
A61K 9/4825
Wall or shell material: proteins, e.g. gelatin
A61K 9/4858
Filling excipients; Inactive ingredients: organic compounds
A61K 47/26
Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite: carbohydrates, e.g. sugar alcohols,…

Family

US 2021/0196698 A1Pre-grant publication · published 1 Jul 2021
US 11,452,722 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results